Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10555-022-10023-9.pdf
Reference58 articles.
1. Ferlay, J. et al. (2018) Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. European Journal of Cancer, 103. Elsevier Ltd, pp. 356–387. https://doi.org/10.1016/j.ejca.2018.07.005.
2. Harbeck, N., et al. (2019) Breast cancer. Nature Reviews Disease Primers, 5(1). https://doi.org/10.1038/s41572-019-0111-2.
3. Tellez-Gabriel, M., Knutsen, E., & Perander, M. (2020). Current status of circulating tumor cells, circulating tumor DNA, and exosomes in breast cancer liquid biopsies. International Journal of Molecular Sciences, 21(24):1–23. https://doi.org/10.3390/ijms21249457. (MDPI AG)
4. Turashvili, G., & Brogi, E. (2014) Tumor heterogeneity in breast cancer. Frontiers in Medicine, 4(DEC):227. https://doi.org/10.3389/FMED.2017.00227.
5. Joseph, C., Papadaki, A., Althobiti, M., Alsaleem, M., Aleskandarany, M. A., & Rakha, E. A. (2018). Breast cancer intratumour heterogeneity: Current status and clinical implications. Histopathology, 73(5), 717–731. https://doi.org/10.1111/HIS.13642
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Circulating tumor DNA: from discovery to clinical application in breast cancer;Frontiers in Immunology;2024-04-30
2. Case report: From negative to positive: a remarkable journey of ER, PR and HER2 status in a patient with metastatic breast cancer;Frontiers in Oncology;2024-04-26
3. The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective Study;ImmunoTargets and Therapy;2024-02
4. Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives;International Journal of Molecular Sciences;2024-01-26
5. Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway;Journal of Translational Medicine;2024-01-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3